Synergism of TNF and IL-1 in the induction of matrix metalloproteinase-3 in trabecular meshwork.

PURPOSE. TNF and IL-1 increase matrix metalloproteinase-3 (MMP-3) expression in the trabecular meshwork (TM). TNF-a, in combination with IL-1α or IL-1β, produces highly synergistic MMP-3 increases. Possible mechanisms for this synergism in TM cells were investigated. METHODS. Porcine and human TM cells were treated with TNF-a, IL-1α, IL-1β and their combinations. Western immunoblots were used to evaluate MMP-3, MMP-9, MMP-12, TNF-a, IL-1α, IL-1β, IL-6, TNF receptor I (RI), IL-1 RI, and IL-1 RII levels and the phosphorylation of Erk, JNK, and p38 MAP kinases. Dose-response effects for TNF-a, IL-la and IL-1β on MMP-3 were evaluated. Microarray and quantitative RT-PCR were used to determine mRNA levels. MMP-3 transcription rate was assessed by transfecting TM cells with an MMP-3 promoter/ reporter construct. Combined cytokine effects on outflow facility were appraised in perfused anterior segment organ culture. RESULTS. TNF-a, IL-la, and IL-1β each individually increased MMP-3 levels, whereas TNF-a in combination with IL-la or IL-1β produced highly synergistic increases. MMP-9 and MMP-12 levels were also elevated, but only MMP-12 showed synergism. IL-la, IL-1β, and IL-6, but not TNF-a mRNA or protein level, were elevated by these cytokines. Maximum MMP-3 production for individual cytokines, even at high doses, was far less than with dual cytokine doses. Erk 1 and 2, JNK 1 and 2, and p38 a and β phosphorylation increased, but not synergistically. However, phosphorylation of novel isoforms of JNK and p38 δ and γ did show synergism. MMP-3 mRNA levels and transcription rates also demonstrated synergism. TNF-a significantly increased IL-1 RI levels. Synergism in outflow facility was observed with TNF-a and IL-la. CONCLUSIONS. TNF-a, in combination with IL-1α or IL-1β, produced intense synergistic increases in MMP-3 and MMP-12 but not in MMP-9. Induction of IL-1 RI by TNF-a partially explains the synergism. Responses of novel JNK and p38 MAP kinase δ and γ isoforms also partially account for the synergism. Understanding this strong synergistic effect may provide useful insight into optimizing therapeutic regulation of intraocular pressure in glaucoma.